Status
Conditions
Treatments
About
The aim of the study is to determine the prevalence of anal high-risk HPV infection and abnormal cytology in HIV uninfected Men who have sex with men (MSM) using PrEP and HIV infected MSM followed-up at the S-kliniek or HRC of the UZ Brussel. 200 participants will be preferably included in the study. The data will be collected using a self-administered questionnaire where socio-demographic characteristics, health-related issues and sexual behavior will be questioned. Also anal canal sampling will be performed for cytological analysis. For the HIV infected MSM, additional information will be extracted from the patient files: CD4+ T-cell count and nadir and duration of combination antiretroviral therapy.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Exclusion Criteria for MSM using PrEP:
Exclusion Criteria for MSM infected with HPV:
Primary purpose
Allocation
Interventional model
Masking
304 participants in 2 patient groups
Loading...
Central trial contact
Virgini Van Buggenhout; Sabine Allard
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal